55111-399 NDC - LANSOPRAZOLE

Drug Information

Product NDC: 55111-399

Proprietary Name:

Non Proprietary Name: lansoprazole

Active Ingredient(s):
  • 30 mg/1 LANSOPRAZOLE


Administration Route(s):

Dosage Form(s): CAPSULE, DELAYED RELEASE

Pharmacy Class(es):
  • Inhibition Gastric Acid Secretion [PE];
  • Proton Pump Inhibitor [EPC];
  • Proton Pump Inhibitors [MoA]

Labeler Information

Labeler Name: Dr. Reddy's Laboratories Limited
Product Type: BULK INGREDIENT
FDA Application Number:
Marketing Category: DRUG FOR FURTHER PROCESSING
Start Marketing Date:6/20/2013

Package Information

No. Package Code Package Description Billing Unit
155111-399-01100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-399-01)
255111-399-05500 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-399-05)EA
355111-399-3030 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-399-30)
455111-399-6060 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-399-60)
555111-399-791 BLISTER PACK in 1 CARTON (55111-399-79) / 10 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK
655111-399-9090 CAPSULE, DELAYED RELEASE in 1 BOTTLE (55111-399-90)EA
755111-399-922500 CAPSULE, DELAYED RELEASE in 1 POUCH (55111-399-92)

NDC Record

Field Name Field Value Definition
PRODUCT NDC55111-399The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
NON PROPRIETARY NAMElansoprazoleThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMECAPSULE, DELAYED RELEASEThe translation of the dosage form Code submitted by the firm.
START MARKETING DATE10/15/2010This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEANDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEDr.Reddy's Laboratories Ltd.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMELANSOPRAZOLEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH30 
ACTIVE INGRED UNITmg/1 
PRODUCT NDC55111-399The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEBULK INGREDIENTIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
NON PROPRIETARY NAMElansoprazoleThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMECAPSULE, DELAYED RELEASEThe translation of the dosage form Code submitted by the firm.
START MARKETING DATE6/20/2013This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEDRUG FOR FURTHER PROCESSINGProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEDr. Reddy's Laboratories LimitedName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMELANSOPRAZOLEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH30 
ACTIVE INGRED UNITmg/1 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 4/12/2024